Buprenorphine
RB-US-13-0002
Phase 2 small_molecule completed
Quick answer
Buprenorphine for Opioid Use Disorder is a Phase 2 program (small_molecule) at Indivior Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Indivior Europe Limited
- Indication
- Opioid Use Disorder
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed